Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT03463187 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Chronic Plaque Psoriasis

Interventions

BIOLOGICAL: SHR-1314
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.